High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-02
DOI
10.1038/s41598-017-17568-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacologic ascorbate induces neuroblastoma cell death by hydrogen peroxide mediated DNA damage and reduction in cancer cell glycolysis
- (2017) Enlong Ma et al. FREE RADICAL BIOLOGY AND MEDICINE
- CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weeklynab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer
- (2016) E. G. Chiorean et al. ANNALS OF ONCOLOGY
- Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer
- (2016) Hideki Ueno et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Tumor cells have decreased ability to metabolize H2O2: Implications for pharmacological ascorbate in cancer therapy
- (2016) Claire M. Doskey et al. Redox Biology
- The unpaved journey of vitamin C in cancer treatment
- (2015) Qi Chen et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- The CBS/CSE system: a potential therapeutic target in NAFLD?
- (2015) Lindsei K. Sarna et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Role of labile iron in the toxicity of pharmacological ascorbate
- (2015) Juan Du et al. FREE RADICAL BIOLOGY AND MEDICINE
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- (2015) D. Goldstein et al. JNCI-Journal of the National Cancer Institute
- Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
- (2015) J. Yun et al. SCIENCE
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- (2015) D. Goldstein et al. JNCI-Journal of the National Cancer Institute
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
- (2014) Berna C. Özdemir et al. CANCER CELL
- Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells
- (2014) Lakshmi Reddy Bollu et al. CELL CYCLE
- Radiosensitisation by pharmacological ascorbate in glioblastoma multiforme cells, human glial cells, and HUVECs depends on their antioxidant and DNA repair capabilities and is not cancer specific
- (2014) M. Leticia Castro et al. FREE RADICAL BIOLOGY AND MEDICINE
- High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
- (2014) Y. Ma et al. Science Translational Medicine
- Epigenetic Impacts of Ascorbate on Human Metastatic Melanoma Cells
- (2014) Sascha Venturelli et al. Frontiers in Oncology
- Parenteral Ascorbate As a Cancer Therapeutic: A Reassessment Based on Pharmacokinetics
- (2013) Nermi L. Parrow et al. ANTIOXIDANTS & REDOX SIGNALING
- Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer
- (2013) Dong-sheng Zhang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
- (2013) J. L. Welsh et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The ROS-induced cytotoxicity of ascorbate is attenuated by hypoxia and HIF-1alpha in the NCI60 cancer cell lines
- (2013) Tobias Sinnberg et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A Convenient Method for Measuring Blood Ascorbate Concentrations in Patients Receiving High-Dose Intravenous Ascorbate
- (2013) Yan Ma et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- EMT and Dissemination Precede Pancreatic Tumor Formation
- (2012) Andrew D. Rhim et al. CELL
- Sirtuins: NAD+-dependent deacetylase mechanism and regulation
- (2012) Anthony A Sauve et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Enhanced antitumor activity of vitamin C via p53 in Cancer cells
- (2012) Jinsun Kim et al. FREE RADICAL BIOLOGY AND MEDICINE
- SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment
- (2012) S-W Hong et al. ONCOGENE
- Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
- (2012) Daniel A. Monti et al. PLoS One
- Desmoplasia in Pancreatic Cancer. Can We Fight It?
- (2012) E. E. Merika et al. Gastroenterology Research and Practice
- Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer
- (2011) Michael Graham Espey et al. FREE RADICAL BIOLOGY AND MEDICINE
- High dose of ascorbic acid induces cell death in mesothelioma cells
- (2010) Yukitoshi Takemura et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- H2O2-mediated Cytotoxicity of Pharmacologic Ascorbate Concentrations to Neuroblastoma Cells: Potential Role of Lactate and Ferritin
- (2010) Beate Deubzer et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The ins and outs of tubulin acetylation: More than just a post-translational modification?
- (2010) Daniel Perdiz et al. CELLULAR SIGNALLING
- Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer
- (2010) J. Du et al. CLINICAL CANCER RESEARCH
- Evolution of systemic therapy for advanced pancreatic cancer
- (2010) Daniel Renouf et al. Expert Review of Anticancer Therapy
- Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)
- (2010) L. Dahan et al. GUT
- FOLFIRINOX: a new standard treatment for advanced pancreatic cancer?
- (2010) Richard Kim LANCET ONCOLOGY
- Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects
- (2009) Julien Verrax et al. FREE RADICAL BIOLOGY AND MEDICINE
- Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
- (2008) L. J. Hoffer et al. ANNALS OF ONCOLOGY
- Tubulin modifications and their cellular functions
- (2008) Jennetta W Hammond et al. CURRENT OPINION IN CELL BIOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice
- (2008) Q. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
- Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry
- (2007) Elena Marangon et al. JOURNAL OF MASS SPECTROMETRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started